
TG Therapeutics to Join TD Cowen Immunology & Inflammation Summit

TG Therapeutics Inc. will participate in the TD Cowen Immunology & Inflammation Summit on November 12-13, 2025. CEO Michael S. Weiss will join a fireside chat on November 12 at 10:00 AM ET, with a live webcast available on the company's website. This announcement was generated by Public Technologies and is for informational purposes only.
TG Therapeutics Inc. will participate in the TD Cowen Immunology & Inflammation Summit, taking place virtually from November 12 to 13, 2025. Chairman and CEO Michael S. Weiss will join a fireside chat scheduled for November 12, 2025, at 10:00 AM ET. A live webcast of the session will be available on the company’s website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TG Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9572559-en) on November 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

